Lars Grundemar
Direttore/Membro del Consiglio presso Reccan Diagnostics AB
Profilo
Lars Grundemar is currently the Director at Reccan Diagnostics AB.
He was previously the Chief Executive Officer at Oncorena AB and Oncorena Holding AB.
Posizioni attive di Lars Grundemar
| Società | Posizione | Inizio |
|---|---|---|
Reccan Diagnostics AB
 Reccan Diagnostics AB Pharmaceuticals: MajorHealth Technology Reccan Diagnostics AB provides cancer diagnosis and treatment. It offers tumor specific diagnosis, prognosis, prediction, and treatment selection with tumor specific directed therapy; and provides tumor-specific biomarkers for diagnosis and treatment selection. The company was founded by Gyorgy Marko-Varga, Roland Andersson, and Daniel Ansari and is headquartered in Lund, Sweden. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Lars Grundemar
| Società | Posizione | Fine |
|---|---|---|
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Amministratore Delegato | 20/06/2022 |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Reccan Diagnostics AB
Reccan Diagnostics AB Pharmaceuticals: MajorHealth Technology Reccan Diagnostics AB provides cancer diagnosis and treatment. It offers tumor specific diagnosis, prognosis, prediction, and treatment selection with tumor specific directed therapy; and provides tumor-specific biomarkers for diagnosis and treatment selection. The company was founded by Gyorgy Marko-Varga, Roland Andersson, and Daniel Ansari and is headquartered in Lund, Sweden. | Health Technology |
Oncorena Holding AB
Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Lars Grundemar
